Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 3Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 3Thoracic 1Plasma cell 1

Conditions

Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Hodgkin Disease 1

Interventions

Cyclophosphamide 30Rituximab 23zanubrutinib 18fludarabine 14Vincristine 14venetoclax 13Prednisone 13blinatumomab 12Magnetic Resonance Spectroscopy 12Specimen Handling 11Doxorubicin 11obinutuzumab 10Bendamustine Hydrochloride 10Lenalidomide 9Dexamethasone 8polatuzumab vedotin 7glofitamab 7Methotrexate 7Radiotherapy 6Prednisolone 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Cytarabine 6Biopsy 6pirtobrutinib 5pegaspargase 5Immunotherapy, Adoptive 5tislelizumab 4tafasitamab 4selinexor 4orelabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Neuropsychological Tests × Lymphoid × Clear all
NCT07558057 2026-04-30

COGNITOX

University of Aarhus

Not yet recruiting
225 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell, Marginal Zone

NCT05416554 2025-02-11

Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

Stanford University

Phase NA Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT06116929 2024-02-28

FunC-AHOD

Lille Catholic University

Phase NA Not yet recruiting
63 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡